Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Report ID: 1972579 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Treatment Method
        1.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Treatment Method: 2017 VS 2021 VS 2028
        1.2.2 Androgen Receptor-Directed Therapy
        1.2.3 Taxane-Based Chemotherapy
    1.3 Market by Application
        1.3.1 Global Prostate Cancer Diagnostics and Therapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prostate Cancer Diagnostics and Therapy Market Perspective (2017-2028)
    2.2 Prostate Cancer Diagnostics and Therapy Growth Trends by Region
        2.2.1 Prostate Cancer Diagnostics and Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prostate Cancer Diagnostics and Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Prostate Cancer Diagnostics and Therapy Market Dynamics
        2.3.1 Prostate Cancer Diagnostics and Therapy Industry Trends
        2.3.2 Prostate Cancer Diagnostics and Therapy Market Drivers
        2.3.3 Prostate Cancer Diagnostics and Therapy Market Challenges
        2.3.4 Prostate Cancer Diagnostics and Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue
        3.1.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue (2017-2022)
        3.1.2 Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Prostate Cancer Diagnostics and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prostate Cancer Diagnostics and Therapy Revenue
    3.4 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio
        3.4.1 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics and Therapy Revenue in 2021
    3.5 Prostate Cancer Diagnostics and Therapy Key Players Head office and Area Served
    3.6 Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
    3.7 Date of Enter into Prostate Cancer Diagnostics and Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics and Therapy Breakdown Data by Treatment Method
    4.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Treatment Method (2017-2022)
    4.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Treatment Method (2023-2028)
5 Prostate Cancer Diagnostics and Therapy Breakdown Data by Application
    5.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
    6.2 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
    6.3 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
    7.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
    7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
    9.2 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
    9.3 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Ipsen SA
        11.1.1 Ipsen SA Company Detail
        11.1.2 Ipsen SA Business Overview
        11.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Introduction
        11.1.4 Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.1.5 Ipsen SA Recent Development
    11.2 Pfizer Inc.
        11.2.1 Pfizer Inc. Company Detail
        11.2.2 Pfizer Inc. Business Overview
        11.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Introduction
        11.2.4 Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.2.5 Pfizer Inc. Recent Development
    11.3 Johnson & Johnson Services Inc.
        11.3.1 Johnson & Johnson Services Inc. Company Detail
        11.3.2 Johnson & Johnson Services Inc. Business Overview
        11.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Introduction
        11.3.4 Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.3.5 Johnson & Johnson Services Inc. Recent Development
    11.4 Bayer AG
        11.4.1 Bayer AG Company Detail
        11.4.2 Bayer AG Business Overview
        11.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Introduction
        11.4.4 Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.4.5 Bayer AG Recent Development
    11.5 Abbvie Inc.
        11.5.1 Abbvie Inc. Company Detail
        11.5.2 Abbvie Inc. Business Overview
        11.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Introduction
        11.5.4 Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.5.5 Abbvie Inc. Recent Development
    11.6 Merck & Co. Inc.
        11.6.1 Merck & Co. Inc. Company Detail
        11.6.2 Merck & Co. Inc. Business Overview
        11.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Introduction
        11.6.4 Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.6.5 Merck & Co. Inc. Recent Development
    11.7 AstraZeneca PLC
        11.7.1 AstraZeneca PLC Company Detail
        11.7.2 AstraZeneca PLC Business Overview
        11.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Introduction
        11.7.4 AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.7.5 AstraZeneca PLC Recent Development
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Detail
        11.8.2 Thermo Fisher Scientific Business Overview
        11.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Introduction
        11.8.4 Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.8.5 Thermo Fisher Scientific Recent Development
    11.9 Dendreon Pharmaceuticals LLC
        11.9.1 Dendreon Pharmaceuticals LLC Company Detail
        11.9.2 Dendreon Pharmaceuticals LLC Business Overview
        11.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Introduction
        11.9.4 Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.9.5 Dendreon Pharmaceuticals LLC Recent Development
    11.10 F. Hoffmann-La Roche Ltd
        11.10.1 F. Hoffmann-La Roche Ltd Company Detail
        11.10.2 F. Hoffmann-La Roche Ltd Business Overview
        11.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Introduction
        11.10.4 F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.10.5 F. Hoffmann-La Roche Ltd Recent Development
    11.11 Hologic Inc.
        11.11.1 Hologic Inc. Company Detail
        11.11.2 Hologic Inc. Business Overview
        11.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Introduction
        11.11.4 Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.11.5 Hologic Inc. Recent Development
    11.12 Astellas Pharma Inc.
        11.12.1 Astellas Pharma Inc. Company Detail
        11.12.2 Astellas Pharma Inc. Business Overview
        11.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Introduction
        11.12.4 Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.12.5 Astellas Pharma Inc. Recent Development
    11.13 Koninklijke Philips NV
        11.13.1 Koninklijke Philips NV Company Detail
        11.13.2 Koninklijke Philips NV Business Overview
        11.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Introduction
        11.13.4 Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.13.5 Koninklijke Philips NV Recent Development
    11.14 Sanofi-Aventis
        11.14.1 Sanofi-Aventis Company Detail
        11.14.2 Sanofi-Aventis Business Overview
        11.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Introduction
        11.14.4 Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
        11.14.5 Sanofi-Aventis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Treatment Method (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Androgen Receptor-Directed Therapy
    Table 3. Key Players of Taxane-Based Chemotherapy
    Table 4. Global Prostate Cancer Diagnostics and Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2017-2022)
    Table 8. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2023-2028)
    Table 10. Prostate Cancer Diagnostics and Therapy Market Trends
    Table 11. Prostate Cancer Diagnostics and Therapy Market Drivers
    Table 12. Prostate Cancer Diagnostics and Therapy Market Challenges
    Table 13. Prostate Cancer Diagnostics and Therapy Market Restraints
    Table 14. Global Prostate Cancer Diagnostics and Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate Cancer Diagnostics and Therapy Market Share by Players (2017-2022)
    Table 16. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2021)
    Table 17. Ranking of Global Top Prostate Cancer Diagnostics and Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
    Table 21. Date of Enter into Prostate Cancer Diagnostics and Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
    Table 24. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Treatment Method (2017-2022)
    Table 25. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Treatment Method (2023-2028) & (US$ Million)
    Table 26. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Treatment Method (2023-2028)
    Table 27. Global Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Application (2017-2022)
    Table 29. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Application (2023-2028)
    Table 31. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Ipsen SA Company Detail
    Table 42. Ipsen SA Business Overview
    Table 43. Ipsen SA Prostate Cancer Diagnostics and Therapy Product
    Table 44. Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 45. Ipsen SA Recent Development
    Table 46. Pfizer Inc. Company Detail
    Table 47. Pfizer Inc. Business Overview
    Table 48. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product
    Table 49. Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Inc. Recent Development
    Table 51. Johnson & Johnson Services Inc. Company Detail
    Table 52. Johnson & Johnson Services Inc. Business Overview
    Table 53. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product
    Table 54. Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 55. Johnson & Johnson Services Inc. Recent Development
    Table 56. Bayer AG Company Detail
    Table 57. Bayer AG Business Overview
    Table 58. Bayer AG Prostate Cancer Diagnostics and Therapy Product
    Table 59. Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 60. Bayer AG Recent Development
    Table 61. Abbvie Inc. Company Detail
    Table 62. Abbvie Inc. Business Overview
    Table 63. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product
    Table 64. Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 65. Abbvie Inc. Recent Development
    Table 66. Merck & Co. Inc. Company Detail
    Table 67. Merck & Co. Inc. Business Overview
    Table 68. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product
    Table 69. Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 70. Merck & Co. Inc. Recent Development
    Table 71. AstraZeneca PLC Company Detail
    Table 72. AstraZeneca PLC Business Overview
    Table 73. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product
    Table 74. AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 75. AstraZeneca PLC Recent Development
    Table 76. Thermo Fisher Scientific Company Detail
    Table 77. Thermo Fisher Scientific Business Overview
    Table 78. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product
    Table 79. Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 80. Thermo Fisher Scientific Recent Development
    Table 81. Dendreon Pharmaceuticals LLC Company Detail
    Table 82. Dendreon Pharmaceuticals LLC Business Overview
    Table 83. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product
    Table 84. Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 85. Dendreon Pharmaceuticals LLC Recent Development
    Table 86. F. Hoffmann-La Roche Ltd Company Detail
    Table 87. F. Hoffmann-La Roche Ltd Business Overview
    Table 88. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product
    Table 89. F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 90. F. Hoffmann-La Roche Ltd Recent Development
    Table 91. Hologic Inc. Company Detail
    Table 92. Hologic Inc. Business Overview
    Table 93. Hologic Inc. Prostate Cancer Diagnostics and TherapyProduct
    Table 94. Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 95. Hologic Inc. Recent Development
    Table 96. Astellas Pharma Inc. Company Detail
    Table 97. Astellas Pharma Inc. Business Overview
    Table 98. Astellas Pharma Inc. Prostate Cancer Diagnostics and TherapyProduct
    Table 99. Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 100. Astellas Pharma Inc. Recent Development
    Table 101. Koninklijke Philips NV Company Detail
    Table 102. Koninklijke Philips NV Business Overview
    Table 103. Koninklijke Philips NV Prostate Cancer Diagnostics and TherapyProduct
    Table 104. Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 105. Koninklijke Philips NV Recent Development
    Table 106. Sanofi-Aventis Company Detail
    Table 107. Sanofi-Aventis Business Overview
    Table 108. Sanofi-Aventis Prostate Cancer Diagnostics and TherapyProduct
    Table 109. Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
    Table 110. Sanofi-Aventis Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method: 2021 VS 2028
    Figure 2. Androgen Receptor-Directed Therapy Features
    Figure 3. Taxane-Based Chemotherapy Features
    Figure 4. Global Prostate Cancer Diagnostics and Therapy Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Prostate Cancer Diagnostics and Therapy Report Years Considered
    Figure 9. Global Prostate Cancer Diagnostics and Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate Cancer Diagnostics and Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate Cancer Diagnostics and Therapy Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate Cancer Diagnostics and Therapy Market Share by Players in 2021
    Figure 13. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2021
    Figure 15. North America Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Prostate Cancer Diagnostics and Therapy Market Share by Country (2017-2028)
    Figure 17. United States Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Prostate Cancer Diagnostics and Therapy Market Share by Country (2017-2028)
    Figure 21. Germany Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Share by Region (2017-2028)
    Figure 29. China Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Prostate Cancer Diagnostics and Therapy Market Share by Country (2017-2028)
    Figure 37. Mexico Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Share by Country (2017-2028)
    Figure 41. Turkey Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Ipsen SA Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 44. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 45. Johnson & Johnson Services Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 46. Bayer AG Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 47. Abbvie Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 48. Merck & Co. Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 49. AstraZeneca PLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 51. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 53. Hologic Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 54. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 55. Koninklijke Philips NV Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 56. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ipsen SA
Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Abbvie Inc.
Merck & Co. Inc.
AstraZeneca PLC
Thermo Fisher Scientific
Dendreon Pharmaceuticals LLC
F. Hoffmann-La Roche Ltd
Hologic Inc.
Astellas Pharma Inc.
Koninklijke Philips NV
Sanofi-Aventis
Frequently Asked Questions
Prostate Cancer Diagnostics and Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Diagnostics and Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Diagnostics and Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports